Loading...
The diphenylpyrazole compound anle138b blocks Aβ channels and rescues disease phenotypes in a mouse model for amyloid pathology.
Martinez Hernandez, Ana Urbanke, Hendrik Gillman, Alan L Lee, Joon Ryazanov, Sergey Agbemenyah, Hope Y Benito, Eva Jain, Gaurav Kaurani, Lalit Grigorian, Gayane
Martinez Hernandez, Ana
Urbanke, Hendrik
Gillman, Alan L
Lee, Joon
Ryazanov, Sergey
Agbemenyah, Hope Y
Benito, Eva
Jain, Gaurav
Kaurani, Lalit
Grigorian, Gayane
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2018-01-01
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 1.91 MB
Other Titles
Abstract
Alzheimer's disease is a devastating neurodegenerative disease eventually leading to dementia. An effective treatment does not yet exist. Here we show that oral application of the compound anle138b restores hippocampal synaptic and transcriptional plasticity as well as spatial memory in a mouse model for Alzheimer's disease, when given orally before or after the onset of pathology. At the mechanistic level, we provide evidence that anle138b blocks the activity of conducting Aβ pores without changing the membrane embedded Aβ-oligomer structure. In conclusion, our data suggest that anle138b is a novel and promising compound to treat AD-related pathology that should be investigated further.
Citation
Affiliation
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1757-4684
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 4.0 International